Moshe Talpaz

机构：University of Michigan, Michigan Medicine, Michigan Center for Translational Pathology · ORCID：0000-0003-3361-3981

发表论文 1282 篇 · 总被引 73996 次 · h-index 125

代表论文

• Durable efficacy and long-term safety with pelabresib plus ruxolitinib in JAK Inhibitor–Naive myelofibrosis: 96-week Results from the Phase III MANIFEST-2 study (2025 · Blood · 被引 6)
• Quantitative MRI Assessment of Bone Marrow Disease in Myelofibrosis: A Prospective Study (2025 · Radiology Imaging Cancer · 被引 2)
• RALLY-MF: Initial efficacy of a phase 2 study of DISC-0974, an anti-hemojuvelin antibody, to treat anemia in myelofibrosis. (2026 · Journal of Clinical Oncology · 被引 1)
• From fatal disease to functional cure: 25 years of tyrosine kinase inhibition in chronic myeloid leukemia (2026 · Leukemia · 被引 1)
• Activity of PROTAC MDM2 degrader in primary leukemia cells and PDX models (2026 · Leukemia · 被引 1)
• RALLY MF: A phase 2 Study of DISC-0974, an anti-hemojuvelin antibody, in patients with myelofibrosis and anemia (2025 · Blood · 被引 1)